Masimo Corporation

Financials

Übersicht Finanzbericht Statistik Dividenden

Mittelzufluss aus laufender Geschäftstätigkeit 264.75 M29.4 M94.1 M196.4 M217.8 M 217.8 M Mittelzufluss aus Investitionstätigkeit -37.53 M-1.06 B-81.2 M-51.2 M275.1 M 275.1 M Zahlungsströme aus der Finanzierungstätigkeit -122.4 M520.4 M-57.1 M-125.6 M-520.7 M -520.7 M Freier Cashflow 229.82 M-26.9 M6.4 M145.3 M193.1 M 193.1 M

Masimo Corporation is an American health technology and consumer electronics company headquartered in Irvine, California. The company develops patient monitoring devices, non-invasive sensors, and related software platforms used in hospital and home settings. Masimo has also operated in the consumer audio and wearable device markets. In 2026, Danaher Corporation agreed to acquire the company for $10 billion.

MASI

Financials

Masimo Corporation

Nachrichten

Jefferies hebt Kursziel für Masimo nach Danaher-Deal auf 180 US-Dollar an

Danaher-Übernahme: Raymond James stuft Masimo-Aktie herab

Evercore-Umfrage: Biopharma-Branche plant höhere Ausgaben für 2026

Masimo-Aktie erreicht 52-Wochen-Hoch von 175,91 US-Dollar

Harbor Health Care ETF Q4 2025 Portfolio Review

Owlet Stock Before Q4 Earnings: Buy Now or Wait for Results?

Masimo: EPS verfehlt Schätzungen um 0,01 $ - Umsatz schlechter als erwartet

Masimo earnings missed by $0.01, revenue fell short of estimates

Masimo earnings in focus as Danaher deal looms

PROCEPT BioRobotics Corporation (PRCT) Reports Q4 Loss, Lags Revenue Estimates

Here's Why Masimo (MASI) is a Strong Momentum Stock

Globus Medical (GMED) Surpasses Q4 Earnings and Revenue Estimates